Ultimate magazine theme for WordPress.

Thomas Südhof at GYSS 2022 – Drug Development for Neurodegenerative Disorders


A researcher seeking treatments for neurodegenerative diseases, Prof Thomas Südhof kicked off the final session of the 2022 Global Young Scientists Summit #GYSS2022 today. He showed that he has found a genetic link between mutations in ‘NRXN1’, a protein coding gene, and neuron diseases like autism, Tourette’s Syndrome and schizophrenia. He believes that a major change in ‘CASK’ protein levels could affect synaptic strength, predisposing people to such diseases.


Leave A Reply

Your email address will not be published.